165 related articles for article (PubMed ID: 23770371)
1. Genetically determined ABCB5 functionality correlates with pigmentation phenotype and melanoma risk.
Lin JY; Zhang M; Schatton T; Wilson BJ; Alloo A; Ma J; Qureshi AA; Frank NY; Han J; Frank MH
Biochem Biophys Res Commun; 2013 Jul; 436(3):536-42. PubMed ID: 23770371
[TBL] [Abstract][Full Text] [Related]
2. Profiling of ABC transporters ABCB5, ABCF2 and nestin-positive stem cells in nevi, in situ and invasive melanoma.
Setia N; Abbas O; Sousa Y; Garb JL; Mahalingam M
Mod Pathol; 2012 Aug; 25(8):1169-75. PubMed ID: 22555176
[TBL] [Abstract][Full Text] [Related]
3. Identification of cells initiating human melanomas.
Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
[TBL] [Abstract][Full Text] [Related]
4. Molecular evolutionary analysis of ABCB5: the ancestral gene is a full transporter with potentially deleterious single nucleotide polymorphisms.
Moitra K; Scally M; McGee K; Lancaster G; Gold B; Dean M
PLoS One; 2011 Jan; 6(1):e16318. PubMed ID: 21298007
[TBL] [Abstract][Full Text] [Related]
5. ATP-binding cassette member B5 (ABCB5) promotes tumor cell invasiveness in human colorectal cancer.
Guo Q; Grimmig T; Gonzalez G; Giobbie-Hurder A; Berg G; Carr N; Wilson BJ; Banerjee P; Ma J; Gold JS; Nandi B; Huang Q; Waaga-Gasser AM; Lian CG; Murphy GF; Frank MH; Gasser M; Frank NY
J Biol Chem; 2018 Jul; 293(28):11166-11178. PubMed ID: 29789423
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance is conferred on the model yeast Saccharomyces cerevisiae by expression of full-length melanoma-associated human ATP-binding cassette transporter ABCB5.
Keniya MV; Holmes AR; Niimi M; Lamping E; Gillet JP; Gottesman MM; Cannon RD
Mol Pharm; 2014 Oct; 11(10):3452-62. PubMed ID: 25115303
[TBL] [Abstract][Full Text] [Related]
7. The role of Abcb5 alleles in susceptibility to haloperidol-induced toxicity in mice and humans.
Zheng M; Zhang H; Dill DL; Clark JD; Tu S; Yablonovitch AL; Tan MH; Zhang R; Rujescu D; Wu M; Tessarollo L; Vieira W; Gottesman MM; Deng S; Eberlin LS; Zare RN; Billard JM; Gillet JP; Li JB; Peltz G
PLoS Med; 2015 Feb; 12(2):e1001782. PubMed ID: 25647612
[TBL] [Abstract][Full Text] [Related]
8. Expression of Cell-Surface Marker ABCB5 Causes Characteristic Modifications of Glucose, Amino Acid and Phospholipid Metabolism in the G3361 Melanoma-Initiating Cell Line.
Lutz NW; Banerjee P; Wilson BJ; Ma J; Cozzone PJ; Frank MH
PLoS One; 2016; 11(8):e0161803. PubMed ID: 27560924
[TBL] [Abstract][Full Text] [Related]
9. ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.
Wilson BJ; Saab KR; Ma J; Schatton T; Pütz P; Zhan Q; Murphy GF; Gasser M; Waaga-Gasser AM; Frank NY; Frank MH
Cancer Res; 2014 Aug; 74(15):4196-207. PubMed ID: 24934811
[TBL] [Abstract][Full Text] [Related]
10. Melanoma chemotherapy leads to the selection of ABCB5-expressing cells.
Chartrain M; Riond J; Stennevin A; Vandenberghe I; Gomes B; Lamant L; Meyer N; Gairin JE; Guilbaud N; Annereau JP
PLoS One; 2012; 7(5):e36762. PubMed ID: 22675422
[TBL] [Abstract][Full Text] [Related]
11. The clinical relevance and prognostic significance of adenosine triphosphate ATP-binding cassette (ABCB5) and multidrug resistance (MDR1) genes expression in acute leukemia: an Egyptian study.
Farawela HM; Khorshied MM; Kassem NM; Kassem HA; Zawam HM
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1323-30. PubMed ID: 24804815
[TBL] [Abstract][Full Text] [Related]
12. The influence of nano-TiO2 on metabolic activity, cytotoxicity and ABCB5 mRNA expression in WM-266-4 human metastatic melanoma cell line.
Zdravkovic B; Zdravkovic TP; Zdravkovic M; Strukelj B; Ferk P
J BUON; 2019; 24(1):338-346. PubMed ID: 30941990
[TBL] [Abstract][Full Text] [Related]
13. Deciphering the roles of ABCB5 in normal and cancer cells.
Duvivier L; Gillet JP
Trends Cancer; 2022 Oct; 8(10):795-798. PubMed ID: 35907754
[TBL] [Abstract][Full Text] [Related]
14. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
Lai CY; Schwartz BE; Hsu MY
Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxicity of cucurbitacin E from Citrullus colocynthis against multidrug-resistant cancer cells.
Saeed MEM; Boulos JC; Elhaboub G; Rigano D; Saab A; Loizzo MR; Hassan LEA; Sugimoto Y; Piacente S; Tundis R; Yagi S; Khalid H; Efferth T
Phytomedicine; 2019 Sep; 62():152945. PubMed ID: 31132750
[TBL] [Abstract][Full Text] [Related]
16. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.
Linley AJ; Mathieu MG; Miles AK; Rees RC; McArdle SE; Regad T
J Biol Chem; 2012 Apr; 287(17):13633-43. PubMed ID: 22393060
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
Xiao J; Egger ME; McMasters KM; Hao H
BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
[TBL] [Abstract][Full Text] [Related]
18. ABCB5 is activated by MITF and β-catenin and is associated with melanoma differentiation.
Louphrasitthiphol P; Chauhan J; Goding CR
Pigment Cell Melanoma Res; 2020 Jan; 33(1):112-118. PubMed ID: 31595650
[TBL] [Abstract][Full Text] [Related]
19. Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.
Czyz M; Koprowska K; Sztiller-Sikorska M
Cancer Biol Ther; 2013 Feb; 14(2):135-45. PubMed ID: 23192276
[TBL] [Abstract][Full Text] [Related]
20. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.
Frank NY; Margaryan A; Huang Y; Schatton T; Waaga-Gasser AM; Gasser M; Sayegh MH; Sadee W; Frank MH
Cancer Res; 2005 May; 65(10):4320-33. PubMed ID: 15899824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
